AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis
Authors: Moller, B Kukoc-Zivojnov, N Kessler, U Rehart, S Kaltwasser, JP Hoelzer, D Kalina, U Ottmann, OG
Citation: B. Moller et al., Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis, RHEUMATOLOG, 40(3), 2001, pp. 302-309
Interleukin 3 improves the ex vivo expansion of primitive human cord bloodprogenitor cells and maintains the engraftment potential of SCID repopulating cells
Authors: Rossmanith, T Schroder, B Bug, G Muller, P Klenner, T Knaus, R Hoelzer, D Ottmann, OG
Citation: T. Rossmanith et al., Interleukin 3 improves the ex vivo expansion of primitive human cord bloodprogenitor cells and maintains the engraftment potential of SCID repopulating cells, STEM CELLS, 19(4), 2001, pp. 313-320
Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34(+) cell expansion and maturation
Authors: Koschmieder, S Bug, G Schroder, B Rossmanith, T Hofmann, WK Kalina, U Hoelzer, D Ottmann, OG
Citation: S. Koschmieder et al., Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34(+) cell expansion and maturation, INT J HEMAT, 73(1), 2001, pp. 71-77
TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34(+) cells from healthy donors, but not from patients with AML after MDS
Authors: Koschmieder, S Hofmann, WK Kunert, J Wagner, S Ballas, K Seipelt, G Hoelzer, D Ottmann, OG Kalina, U
Citation: S. Koschmieder et al., TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34(+) cells from healthy donors, but not from patients with AML after MDS, LEUKEMIA, 15(6), 2001, pp. 942-949
Transforming growth factor-beta(1) interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells
Authors: Kalina, U Koschmieder, S Hofmann, WK Wagner, S Kauschat, D Hoelzer, D Ottmann, OG
Citation: U. Kalina et al., Transforming growth factor-beta(1) interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells, EXP HEMATOL, 29(5), 2001, pp. 602-608
Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosomep11.23 by in situ hybridization
Authors: Mahlknecht, U Schnittger, S Landgraf, F Schoch, C Ottmann, OG Hiddemann, W Hoelzer, D
Citation: U. Mahlknecht et al., Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosomep11.23 by in situ hybridization, CYTOG C GEN, 93(1-2), 2001, pp. 135-136
Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation
Authors: Wassmann, B Klein, SA Scheuring, U Pfeifer, H Martin, H Gschaidmeier, H Hoelzer, D Ottmann, OG
Citation: B. Wassmann et al., Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation, BONE MAR TR, 28(7), 2001, pp. 721-724
Far-Western based protein-protein interaction screening of high-density protein filter arrays
Authors: Mahlknecht, U Ottmann, OG Hoelzer, D
Citation: U. Mahlknecht et al., Far-Western based protein-protein interaction screening of high-density protein filter arrays, J BIOTECH, 88(2), 2001, pp. 89-94
Interleukin-18 stimulates HIV-1 replication in a T-cell line
Authors: Klein, SA Klebba, C Kauschat, D Pape, M Ozmen, L Hoelzer, D Ottmann, OG Kalina, U
Citation: Sa. Klein et al., Interleukin-18 stimulates HIV-1 replication in a T-cell line, EUR CYTOKIN, 11(1), 2000, pp. 47-51
Cytokine therapy for myelodysplastic syndrome
Authors: Seipelt, G Ottmann, OG Hoelzer, D
Citation: G. Seipelt et al., Cytokine therapy for myelodysplastic syndrome, CURR OPIN H, 7(3), 2000, pp. 156-160
Defective megakaryocytic development in myelodysplastic syndromes
Authors: Hofmann, WK Kalina, U Koschmieder, S Seipelt, G Hoelzer, D Ottmann, OG
Citation: Wk. Hofmann et al., Defective megakaryocytic development in myelodysplastic syndromes, LEUK LYMPH, 38(1-2), 2000, pp. 13-19
Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4(+) T cells in vitro
Authors: Klebba, C Ottmann, OG Scherr, M Pape, M Engels, JW Grez, M Hoelzer, D Klein, SA
Citation: C. Klebba et al., Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4(+) T cells in vitro, GENE THER, 7(5), 2000, pp. 408-416
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels
Authors: Hofmann, WK Seipelt, G Ottmann, OG Kalina, U Koschmieder, S Brucher, J Frickhofen, N Klausmann, M Mitrou, PS Hoelzer, D
Citation: Wk. Hofmann et al., Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels, ANN HEMATOL, 79(5), 2000, pp. 255-258
When the band begins to play: Histone acetylation caught in the crossfire of gene control
Authors: Mahlknecht, U Ottmann, OG Hoelzer, D
Citation: U. Mahlknecht et al., When the band begins to play: Histone acetylation caught in the crossfire of gene control, MOL CARCINO, 27(4), 2000, pp. 268-271
Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes
Authors: Kalina, U Hofmann, WK Koschmieder, S Wagner, S Kauschat, D Hoelzer, D Ottmann, OG
Citation: U. Kalina et al., Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes, EXP HEMATOL, 28(10), 2000, pp. 1158-1163
Genomic organization and regulation of the human interleukin-18 gene
Authors: Kalina, U Ballas, K Koyama, N Kauschat, D Miething, C Arnemann, J Martin, H Hoelzer, D Ottmann, OG
Citation: U. Kalina et al., Genomic organization and regulation of the human interleukin-18 gene, SC J IMMUN, 52(6), 2000, pp. 525-530
Chromosomal organization and localization of the human histone deacetylase5 gene (HDAC5)
Authors: Mahlknecht, U Schnittger, S Ottmann, OG Schoch, C Mosebach, M Hiddemann, W Hoelzer, D
Citation: U. Mahlknecht et al., Chromosomal organization and localization of the human histone deacetylase5 gene (HDAC5), BBA-GENE ST, 1493(3), 2000, pp. 342-348
IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 andby the extracellular regulated kinases p44(erk-1) and p42(erk-21)
Authors: Kalina, U Kauschat, D Koyama, N Nuernberger, H Ballas, K Koschmieder, S Bug, G Hofmann, WK Hoelzer, D Ottmann, OG
Citation: U. Kalina et al., IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 andby the extracellular regulated kinases p44(erk-1) and p42(erk-21), J IMMUNOL, 165(3), 2000, pp. 1307-1313
BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity
Authors: Puccetti, E Guller, S Orleth, A Bruggenolte, N Hoelzer, D Ottmann, OG Ruthardt, M
Citation: E. Puccetti et al., BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity, CANCER RES, 60(13), 2000, pp. 3409-3413
Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction
Authors: Klein, SA Ottmann, OG Ballas, K Dobmeyer, TS Pape, M Weidmann, E Hoelzer, D Kalina, U
Citation: Sa. Klein et al., Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction, CYTOKINE, 11(6), 1999, pp. 451-458
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
Authors: Hofmann, WK Ganser, A Seipelt, G Ottmann, OG Zander, C Geissler, G Hoffmann, K Hoffken, K Fischer, JT Isele, G Hoelzer, D
Citation: Wk. Hofmann et al., Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor, ANN HEMATOL, 78(3), 1999, pp. 125-130
Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alpha
Authors: Hofmann, WK Kalina, U Seipelt, G Hoffmann, K Wagner, S Hoelzer, D Ottmann, OG
Citation: Wk. Hofmann et al., Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alpha, EUR J HAEMA, 62(5), 1999, pp. 336-340
Clinical use of thrombopoietin
Authors: Ottmann, OG Hoelzer, D Hofmann, WK
Citation: Og. Ottmann et al., Clinical use of thrombopoietin, LEUKEMIA, 13(9), 1999, pp. 1471-1472
Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
Authors: Hofmann, WK Ottmann, OG Hoelzer, D
Citation: Wk. Hofmann et al., Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?, LEUKEMIA, 13(1), 1999, pp. 14-18
Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
Authors: Hofmann, WK Ottmann, OG Hoelzer, D
Citation: Wk. Hofmann et al., Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?, LEUKEMIA, 13, 1999, pp. S14-S18
Risultati: 1-25 | 26-31